Schneerson et al., 1982 - Google Patents
Bacterial capsular polysaccharide conjugates.Schneerson et al., 1982
- Document ID
- 12674833154184571820
- Author
- Schneerson R
- Robbins J
- Egan W
- Zon G
- Sutton A
- Vann W
- Kaijser B
- Publication year
- Publication venue
- SEMIN. INFECT. DIS. 1982.
External Links
- 150000004676 glycans 0 title abstract description 8
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
- A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
- A61K47/4833—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4619828A (en) | Polysaccharide exotoxoid conjugate vaccines | |
FI79024C (en) | Process for the preparation of Haemophilus influenzae b-polysaccharide xotoxoid conjugate vaccine. | |
US4711779A (en) | Glycoproteinic conjugates having trivalent immunogenic activity | |
US5955079A (en) | Dual carrier immunogenic construct | |
EP0720485B1 (en) | Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs | |
CA2142981C (en) | Vaccines against group c neisseria meningitidis | |
US5445817A (en) | Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines | |
AU740784B2 (en) | Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines | |
US4644059A (en) | Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine | |
MC2178A1 (en) | PNEUMOLYSIN MUTANTS AND PNEUMOCOCCUS-BASED VACCINES MADE FROM THESE MUTANTS | |
Bergquist et al. | Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates | |
US4771127A (en) | Nontoxic pseudomonas aeruginosa polysaccharide-tetanus toxoid and polysaccharide-toxin a conjugate vaccines | |
AU627455B2 (en) | Haemophilus influenza type B oxidized polysaccharide-outer membrane protein conjugate vaccine | |
Schneerson et al. | Bacterial capsular polysaccharide conjugates. | |
Peeters et al. | Preparation of polysaccharide-conjugate vaccines | |
Paoletti et al. | Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen | |
JP2000507252A (en) | Method and vaccine for producing immunological substance | |
Pier et al. | Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 Pseudomonas aeruginosa | |
Michon et al. | Combination conjugate vaccines against multiple serotypes of group B streptococci | |
Schneerson et al. | Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6 SA polysaccharide-protein conjugates. | |
Guo et al. | Studies on meningococcal polysaccharide-tetanus toxoid conjugates. | |
JP2012116850A (en) | Production of immunogenic construct using soluble carbohydrate activated via organic cyanylating reagent | |
NO157603B (en) | PROCEDURE FOR THE PREPARATION OF A WATER-SUBSTANTIAL COVAL NT POLYSACCHARID DIPTERY / TOXOID CONJUGATE AND A HAPTEN, ESSENTIAL FREE OF PROTEIN AND NUCLEIC ACID. |